An 18-year-old man presented to the emergency department after 3 weeks of intermittent headaches. He had experienced dull episodic central-parietal pain occurring 1 to 2 times a day and lasting for approximately 1 hour per episode. Headaches were associated with nausea and occasional projectile vomiting when the headaches were severe. He denied aura, photophobia, phonophobia, or blurred vision. Before arriving at the emergency department, he had his first generalized tonic-clonic event for several minutes. He did not have fever or weight loss. His medical and family histories were unremarkable. He denied having recently traveled.
Section 2
The symptoms of headache, nausea, projectile vomiting, and papilledema could be explained by increased intracranial pressure. Neck stiffness indicates involvement of the meninges, and seizures suggest cortex involvement. The localization common to each of these features is the meningeal space. The patient's history indicated an insidious onset process developing over 3 weeks that strongly suggested chronic meningitis (though some authors prefer waiting 4 weeks before making the distinction between chronic and acute meningitis).
The differential diagnosis of chronic aseptic meningitis is broad (table) . In general, patients with chronic meningitis should be asked about travel to or residence in epidemic areas. The immune status should be assessed by history and laboratory testing. Recent medications should be carefully reviewed. Patients with chronic meningitis usually undergo several diagnostic tests, including serology, imaging, and lumbar puncture. Brain or meningeal biopsy may be helpful in patients who have undergone aggressive but ineffective empiric treatment and have progressive deterioration, especially when neuroimaging shows focal findings.
For this patient, routine laboratory tests, including serum screening for rheumatism and vasculitis, serology for HIV and syphilis, and angiotensin-converting enzyme (ACE) level measurement, were normal. A whole-body CT scan did not show any evidence of underlying malignancy. Brain MRI showed diffuse enhancement along the leptomeninges on the surface of the cerebral hemispheres, cerebellum, and brainstem.
On lumbar puncture, the opening pressure was over 400 mmH 2 O, and the CSF was xanthochromic. The white cell count was elevated (23/mm 3 ); lymphocytes were predominant. The protein level was 1,400 mg/dL, the CSF glucose level 1 mmol/L, and chloride 108 mmol/L. The CSF acid-fast stain, T-SPOT.TB assay, and India ink stain findings were normal. CSF cultures were negative for bacteria, tuberculosis, and fungi. CSF cytology was negative for malignancy.
Question:
1. How do auxiliary tests help narrow the differential diagnosis in this case? Abbreviations: CMV = cytomegalovirus; EBV = Epstein-Barr virus; HaNDL = transient headache and neurologic deficits with CSF lymphocytosis; HSV = herpes simplex virus; HTLV = human T-cell lymphotropic virus; IVIg = IV immunoglobulin; NSAID = nonsteroidal anti-inflammatory drug; VZV = varicella-zoster virus. a Initial laboratory estimation in this case.
Section 3
In this case, the CSF profile of hypoglycorrhachia, high protein level, and mild mononuclear pleocytosis helped confine the differential diagnosis to tuberculosis, fungi, sarcoidosis, and neoplasms. The serum and CSF screens for tuberculosis and fungi were normal. The absence of fever or apparent immunocompromise did not support obvious infectious causes. The lack of parenchymal mass lesions and systemic findings argued against neoplastic meningitis. Further, the CSF cytology was negative for malignancy. Neither image nor serum ACE screening supported the suspicion of sarcoidosis.
Considering the incidence of tuberculosis in the patient's residence area, and the high morbidity and mortality of tuberculous meningitis if treatment is delayed, we empirically administered antituberculous drugs, as well as mannitol and levetiracetam. After a month's therapy, however, the meningism worsened. Further, the patient's vision gradually declined. Repeated brain MRI revealed ventriculomegaly (figure1A). To control the intracranial pressure, an Ommaya reservoir was implanted for continuous CSF drainage. Prednisone was administered to relieve potential meningeal adhesions. Considering the poor response to antituberculous therapy, empiric antifungals were added for another month. At the end of the third month, the meningism improved, and the patient was discharged. He continued with the antituberculous drugs and prednisone. At the end of the fifth month's follow-up, his vision was below light perception. Because of prolonged bed rest and insufficient rehabilitation, his muscle mass had decreased and his extremities Medical Research Council (MRC) grade was 4+.
On the seventh month, the patient was readmitted because of progressive weakness of all extremities over 1 week. On physical examination, his extremities MRC grade was 0/5. His reflexes were diminished. The Babinski sign was positive bilaterally. Pinprick sensation below the T4 level and vibration sensation of the lower extremities had disappeared. Neck stiffness remained. 
Section 4
Based on the symptoms, we inferred spinal cord involvement. Spinal MRI with gadolinium enhancement revealed striking diffuse thickened leptomeninges, coating the whole spinal cord, from the medulla oblongata to the cauda equina ( figure 1, B-D) . The lower segment of the thoracic spinal cord presented swelling with slightly prolonged T1 and T2 signals. Repeated lumbar puncture drained the xanthochromic and viscous CSF. The cell count was normal. The CSF protein level was higher than 5,000 mg/dL. The glucose level decreased to 0.5 mmol/L. The CSF cytology was still negative for malignancy. Meanwhile, we examined the ventricular CSF through the Ommaya reservoir; the protein level was 402 mg/dL and the glucose level 2.9 mmol/L.
Due to treatment failure and CNS parenchyma involvement, we reconsidered meningeal carcinomatosis. To establish the final diagnosis, a meningeal biopsy was performed at the lower thoracic segment, and pathologic analysis revealed primary diffuse leptomeningeal gliomatosis, WHO grade II-III (probable pleomorphic xanthoastrocytoma; figure e-1, links.lww.com/WNL/A501). Chemotherapy was recommended, but the patient discharged himself and there was no follow-up.
Discussion
Primary diffuse leptomeningeal gliomatosis (PDLG) is characterized by diffuse infiltration of neoplastic glial cells in the leptomeninges, without evidence of a primary intraparenchymal tumor.
1 PDLG is very rare; it tends to affect adults and a male predominance is observed. 2, 3 The proliferating neoplastic cells are more frequently of astrocytic origin. 3 However, to our knowledge, pleomorphic xanthoastrocytoma presenting with PDLG has not been previously reported.
The neurologic symptoms of PDLG can mimic chronic meningitis or polyradiculopathy. 2 Typically, patients present early with elevated intracranial pressure. Visual loss is presumably due to increased intracranial pressure or focal involvement of the optic nerves, and seizures may ensue. 2 Imaging features include diffuse leptomeningeal contrast enhancement, spinal cord involvement, and ventriculomegaly. PDLG should have simple diffuse leptomeningeal involvement. However, some parenchymal involvement may appear, involving the superficial parenchyma or Virchow-Robin spaces. 4 CSF cytology is essential for diagnosis of secondary leptomeningeal carcinomatosis. However, CSF examination infrequently detects malignant cells in PDLG. 3 In one review on PDLG, cytologies were positive in 5 of 45 reported cases. 5 Hypoglycorrhachia may occur in PDLG, and the CSF protein level is often high. 2 Chloride concentration reduction is likely a response to elevated CSF protein level to maintain the osmotic pressure balance between CSF and plasma. Generally, high protein concentration in the CSF is nonspecific. However, a protein level of more than 5,000 mg/dL is very rare. The moderately elevated protein and slightly decreased glucose ventricular CSF levels suggested blockage of the spinal canal by thickened neoplastic leptomeninges and secretion of malignant cells.
The main differential diagnosis of PDLG is tuberculous meningitis. Treatment with antituberculous therapy is not uncommon. 1, 5 Optimally, the CSF specimens should be examined by acid-fast stain and culture to confirm tuberculous meningitis. A study involving 132 patients found that a bacteriologic diagnosis was achieved in 82% of cases; acidfast bacilli (AFB) smear and culture were positive in 58% and 71% of cases, respectively. 6 In one series study, 37% of cases were diagnosed based on an initial AFB smear; the diagnostic yield increased to 87% when up to 4 serial specimens were examined, even if antituberculosis therapy had been initiated before a positive smear result was obtained. 7 Nucleic acid amplification (NAA) tests appear to have high specificity but only moderate sensitivity, 8 suggesting that negative NAA results cannot be used to exclude tuberculous meningitis.
The diagnosis of PDLG is challenging. The duration from onset to final diagnosis in this case was 33 weeks. Debono et al. 9 proposed the following diagnostic criteria: (1) no apparent attachment of extramedullary meningeal tumor to the neural parenchyma; (2) no evidence of primary neoplasia within the neuraxis; (3) existence of distinct leptomeningeal encapsulation around the tumor. PDLG is usually diagnosed by meningeal biopsy or autopsy. There are no guidelines for therapy. A combination of temozolomide and radiotherapy may be beneficial, but the prognosis is poor, with a median survival of 4 months. 5 We suggest that PDLG should be included in the differential diagnosis in cases of increased intracranial pressure with leptomeningeal involvement, especially when tuberculous meningitis is suspected and the patient is unresponsive to treatment. Surgical biopsy can be performed in patients where a precise etiology cannot be otherwise ascertained.
Author contributions
Dr. Jiang: clinical data review, literature review, writing of the first draft. Dr. Han and Dr. Fan: acquisition of data, intellectual contribution on clinical decision-making. Dr. Gao: performing meningeal biopsy, intellectual contribution. Dr. Cui: analyzing the data, intellectual contribution. Dr. Zhong: providing the final pathologic diagnosis, critical revision of the manuscript. Dr. Peng: critical revision of the manuscript for intellectual content, contribution on clinical decision-making.
Study funding
No targeted funding reported.
